merck, qiagen launch rwandan cervical cancer deal
u.s. drugmaker merck and german diagnostics firm qiagen are donating millions of human papillomaviros (hpv) vaccines and 250,000 hpv tests to rwanda to start a national cervical cancer prevention program.
http://feeds.reuters.com/~r/reuters/healthnews/~3/1gabnnqwgzg/us-merck-qiagen-rwanda-idustre73o33320110425
21822
25 Apr 2011 16:13:41
reuters
health